PRESS RELEASE FROM LABORATORY INVESTIGATION
(<http://www.nature.com/labinvest/>)
This press release is copyrighted to the journal Laboratory Investigation.
PLEASE CITE Laboratory Investigation AND THE Laboratory Investigation WEBSITE AS THE SOURCE OF THE FOLLOWING ITEM. IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO www.nature.com/labinvest/ <http://www.nature.com/labinvest/>
Green tea may help to fight lung cancer
DOI: 10.1038/Labinvest.3700534
A possible mechanism for green tea’s anticancer activities is reported online this week in Laboratory Investigation. The reported effect of green tea extract on lung cancer cells supports the increasing evidence of green tea’s anticancer properties.
With an estimated 162,246 deaths in 2006, lung cancer is the most common cause of cancer-related death in the USA. The active constituents of green tea - called polyphenols - are recognized antioxidants, but the extent of any anticancer activity remains unclear. Although animal studies offer strong evidence for the anticancer effect of green tea in several organs, including the lung, human population-based studies have shown green tea to increase, decrease, and have no effect on the risk of lung cancer.
Qing-Yi Lu and colleagues now report that, in lung cancer cells, green tea extract (GTE) promotes the polymerization of the cell protein actin. This action counteracts the depolymerisation of actin that characterizes the early stage of cancer development. Researchers also pointed to annexin-I, the actin-binding protein that mediates the effect of GTE on actin, as a novel potential target for GTE-based cancer therapy. The authors suggest that further research and clinical trials are needed to determine how their results relate to actual green tea consumption.
Author contact:
Jian Yu Rao (University of California at Los Angeles, CA, USA)
Tel: +1 310 794 1567; Email: [email protected]
Editorial contact:
Catherine Ketcham (Laboratory Investigation, Gainesville, FL, USA)
Tel: +1 352 392 2511; Email: [email protected]
Media contacts:
Katherine Anderson (Nature London)
Tel: +44 20 7843 4502; E-mail: [email protected]
Ruth Francis (Senior Press Officer, Nature London)
Tel: +44 20 7843 4562; E-mail: [email protected]
About Nature Publishing Group
Nature Publishing Group (NPG) is a division of Macmillan Publishers Ltd, dedicated to serving the academic, professional scientific and medical communities. NPG's flagship title, Nature, was first published in 1869. Other publications include Nature research journals, Nature Reviews, Nature Clinical Practice and a range of prestigious academic journals including society-owned publications. NPG also provides news content through [email protected] and scientific career information through Naturejobs.
NPG is a global company with headquarters in London and offices in New York, San Francisco, Washington DC, Boston, Tokyo, Paris, Munich, Hong Kong, Melbourne, Delhi, Mexico City and Basingstoke. For more information, please go to www.nature.com <http://www.nature.com>
